TNF inhibitors: Useful additional therapy to methotrexate in rheumatoid arthritis patients with severe disease

dc.contributor.author	Yazici, H.
dc.contributor.author	Yazici, Y.
dc.date.accessioned	2021-03-06T11:59:47Z
dc.date.available	2021-03-06T11:59:47Z
dc.identifier.citation	Yazici Y., Yazici H., "TNF inhibitors: Useful additional therapy to methotrexate in rheumatoid arthritis patients with severe disease", Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Hollanda, 21 - 24 Haziran 2006, cilt.65, ss.513-514
dc.identifier.other	vv_1032021
dc.identifier.other	av_f1b75f0e-94a9-441a-89d4-e7f9030ab9e9
dc.identifier.uri	http://hdl.handle.net/20.500.12627/158584
dc.language.iso	eng
dc.subject	Sağlık Bilimleri
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	İmmünoloji ve Romatoloji
dc.subject	Tıp
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ROMATOLOJİ
dc.title	TNF inhibitors: Useful additional therapy to methotrexate in rheumatoid arthritis patients with severe disease
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	65
dc.contributor.firstauthorID	132557

Files in this item

Files	Size	Format	View
There are no files associated with this item.